Anisperimus
Anisperimus (LF-150195) is an immunosuppressant with the activity of enhancing activation-induced T cell death. Anisperimus enhances the sensitivity of T cells to anti-CD95 antibodies and other inducers by promoting the activation of caspase-8 and caspase-10 at the level of the death-inducing signaling complex (DISC) . Anisperimus also promotes the development of Foxp3-expressing regulatory CD4 T cells, thereby preventing central nervous system autoimmunity[1].
Product Specifications
CAS Number
170368-04-4
Product Name Alternative
LF-150195
UNSPSC
12352211
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/anisperimus.html
Smiles
C[C@@H](N)CCNCCCCNC(OCC(NCCCCCCNC(N)=N)=O)=O
Molecular Formula
C18H39N7O3
Molecular Weight
401.55
References & Citations
[1]LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Serine / Threonine-Protein Phosphatase 2A 56 kDa Regulatory Subunit Alpha Isoform (PPP2R5A) Antibody
TRAF4 (TNF Receptor Associated Factor 4, TNF Receptor-associated Factor 4, TRAF 4, TRAF-4, Cysteine-rich Domain Associated with RING and Traf Domains Protein 1, CART1, Metastatic Lymph Node Gene 62 Protein, MLN 62, MLN62, RING Finger Protein 83, RNF83) (FITC)
4921509C19Rik Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
